ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.60
0.71%
US Tech 100
19,636.04
0.55%
S&P 500
5,770.20
0.55%
US Dollar vs CAD
1.43715
0.00%
Bitcoin
83,527.58
-3.05%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. AcelRX Pharmaceuticals Inc (ACRX) Share Price

AcelRX Pharmaceuticals Inc

AcelRX Pharmaceuticals Inc (ACRX)

NASDAQ
0.86
0.00
(0.00%)
Closed March 09 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.86
Bid
0.861
Ask
0.89
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
14.579M
Previous Close
0.86
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
16,952,000
Dividend Yield
-
PE Ratio
-0.79
Earnings Per Share (EPS)
-1.09
Revenue
651k
Net Profit
-18.4M

About AcelRX Pharmaceuticals Inc

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
talphera.com
Headquarters
Wilmington, Delaware, USA
Founded
-

Ask ADVFN Intelligence (AI)

ACRX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 24 2024
ACRX (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
June 24 2024
ACRX (0.00%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 29 2024
ACRX (0.00%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
April 29 2024
ACRX (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
April 19 2024
ACRX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 21 2024
ACRX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 15 2024
ACRX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 12 2024
ACRX (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
January 09 2024
ACRX (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ACRX - Frequently Asked Questions (FAQ)

What is the current AcelRX Pharmaceuticals share price?
The current share price of AcelRX Pharmaceuticals is US$ 0.86
How many AcelRX Pharmaceuticals shares are in issue?
AcelRX Pharmaceuticals has 16,952,000 shares in issue
What is the market cap of AcelRX Pharmaceuticals?
The market capitalisation of AcelRX Pharmaceuticals is USD 14.58M
What is the 1 year trading range for AcelRX Pharmaceuticals share price?
AcelRX Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of AcelRX Pharmaceuticals?
The price to earnings ratio of AcelRX Pharmaceuticals is -0.79
What is the cash to sales ratio of AcelRX Pharmaceuticals?
The cash to sales ratio of AcelRX Pharmaceuticals is 22.4
What is the reporting currency for AcelRX Pharmaceuticals?
AcelRX Pharmaceuticals reports financial results in USD
What is the latest annual turnover for AcelRX Pharmaceuticals?
The latest annual turnover of AcelRX Pharmaceuticals is USD 651k
What is the latest annual profit for AcelRX Pharmaceuticals?
The latest annual profit of AcelRX Pharmaceuticals is USD -18.4M
What is the registered address of AcelRX Pharmaceuticals?
The registered address for AcelRX Pharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the AcelRX Pharmaceuticals website address?
The website address for AcelRX Pharmaceuticals is talphera.com
Which industry sector does AcelRX Pharmaceuticals operate in?
AcelRX Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.14M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.92M
KZIAKazia Therapeutics Ltd
US$ 1.1899
(40.80%)
4.5M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
570.43k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.54M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.13M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
332.1k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
143.04M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
142.23M

Discussion

View Full Feed
BBANBOB BBANBOB 2 minutes ago
He has an on going selling program and has for yrs now
COOP
bigworld bigworld 2 minutes ago
https://thehill.com/business/5183840-late-car-payments-record-high/amp/

The underlying weakness in the economy has been growing under the radar for years. It was hidden by adding $2 Trillion a year of deficit spending, which has painted us into a corner fiscally. The bubble is going t
iateclube iateclube 4 minutes ago
So this morning on national news there was an interview of a woman whose life was saved by a smart ring, that signalled conditions of lymphoma. Worth $millions in free advertising! Drum roll........ which smart ring was it?

OURA
MILLIONS
bigworld bigworld 6 minutes ago
Financial Intelligence Report

The Newsletter for people willing to take control of their financial future

Contributing Editors: Bob Rinear, Ted, Chuck and the Crew!

Wall Street Lunacy donated by Jerome Powell, and Central Bankers the world over! Who else
al44 al44 7 minutes ago
This Is Gavin Newsom: A Quest for National Relevance

Could the governor’s new gambit increase his presidential prospects?

by Corey Smith | Mar 9, 2025


Just when Democrats seem incapable of saying anything unscripted and against their ideals, Gover
bigworld bigworld 8 minutes ago
gfp: The tariffs are a gambit. They aren't going to be permanent as long as the affected trading partners drop their own tariffs to an equal level and we aren't running Trillion$ trade deficits every year. And the tariffs will induce more companies to set up shop here which is a vital component of T
Remember Tomorrow Remember Tomorrow 9 minutes ago
Your best post ever. Well done.

RT
XRPUSD
PaladinDruid94 PaladinDruid94 9 minutes ago
BNCM could be a game-changer!
BNCM
exwannabe exwannabe 11 minutes ago
Yes EX because surgeons go out of their way to leave tumorous material behind with bad margins so patients don't survive ...
I guess you just do not understand GBM too well.

Upon diagnosis many patients will get a full resection. But many will not, getting either partials or bi
NWBO
Uncle Monkey Uncle Monkey 12 minutes ago
fins confirm no one buys dynamo..

well almost no one
CBRF
quester614 quester614 13 minutes ago
Between the jurisdiction or the default this doesn't stand a chance of making it to trial.
XERI
Uncle Monkey Uncle Monkey 14 minutes ago
wow! must be making huge fees off the ship channel?

hahahahahahah

#FOS_fakenewa
CBRF
lizzy241 lizzy241 14 minutes ago
Sleven, do we know the tariffs will be 20%? No one knows; the last I heard was "reciprocal" tariffs will be imposed. I guess we'll get a better idea during the conf call?
AMRN
Orange Cassidy Orange Cassidy 16 minutes ago
Bring a "depends" thanks live in assistant! 
CGAC
Susie924 Susie924 17 minutes ago
Anyone else watching The Americas narrated by Tom Hanks?

Animals are incredible.
jhdf51 jhdf51 18 minutes ago
Thank you LG.

Regards,

JHD
COOP
Bob_X Bob_X 19 minutes ago
I call BS. You posted pics from over 10 years ago. They are almost out of cash and close to bankruptcy. They don't even have equipment to drill. They are just sucking your investor money until they retire this Summer.
HYMC
dexprs dexprs 20 minutes ago
Elroy, based on your post, what could be his ultimate plan? Living Space in Canada? Keep sickling up tp Putin? Giving away Taiwan? He knows he is a small man, so what could it be?
DrivenByPain DrivenByPain 22 minutes ago
I Searched (SGDH) In Citigroup/Kingdomnovo's Website And This Popped Up .

https://www.kingdomnova.com/search.jsp?id=2360&q=SGDH&fromTopShoppingCart=false

Citigroup and Dr. Huazan reach "Africa consensus" to promote global integration and common prosperity

SGDH
learningcurve2020 learningcurve2020 23 minutes ago
…But this really is a gigantic question and likely why the usual suspects here are trying to ignore it and cast you as a moron.

>>Well, if one has near total resection and no rapid progression on SOC, what is the 5 year OS?

My guess is fairly good based on other trial d
NWBO
chazzy1 chazzy1 25 minutes ago
Good points, Alan, and thank you for bringing your unique perspective to bear on HDC's algorithms.
According to the USPTO, HDC owns the "exclusive rights to all" SVM-RFE technology, so I am not exactly sure if you are referring to new algorithms that fall outside of SVM-RFE, or something else
SVM
govprs govprs 25 minutes ago
Hold? Buy more?  What's Amanda price target can't read that chart from my phone
BIXT
Stinger2014 Stinger2014 26 minutes ago
It’s like fried fish and curry, can’t get rid of that smell…….
CGAC

Your Recent History

NASDAQ
ACRX
AcelRX Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads